Global Health Ltd.
NSE: MEDANTA | BSE: 543654
₹1,405.60
₹-10.80
(-0.76%)
As on 31-Jul-2026IST
Market cap
₹37,868 Cr
Revenue (TTM)
₹4,683 Cr
P/E Ratio
68.1
P/B Ratio
9.2
Div. Yield
0 %
Quality Score
9/10
Growth Score
8/10
Valuation Score
4/10
Momentum Score
7/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹556 Cr
-
ROE
15.3 %
-
ROCE
20.5 %
-
Industry P/E
63.6
-
EV/EBITDA
34.6
-
Debt to Equity
0.1
-
Book Value
₹153.5
-
EPS
₹21.3
-
Face value
2
-
Shares outstanding
268,871,782
10 Years Aggregate
CFO
₹2,788.61 Cr
EBITDA
₹3,843.43 Cr
Net Profit
₹1,861.55 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Global Health
| 18.5 | 7.7 | 23.0 | 7.6 | 25.9 | -- | -- |
|
BSE Healthcare
| 17.0 | 3.6 | 13.8 | 10.8 | 22.3 | 14.2 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Global Health
| 7.8 | 13.4 | 104.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Global Health
|
1,405.6 | 37,867.9 | 4,683.4 | 552.3 | 15.6 | 14.9 | 68.1 | 9.2 |
| 809.2 | 45,563.7 | 2,002.3 | 576.0 | 32.7 | 20.5 | 79.1 | 14.6 | |
| 1,905.2 | 31,976.9 | 2,890.8 | 546.3 | 23.0 | 23 | 59 | 12.2 | |
| 2.9 | 15.6 | 0.2 | -8.4 | -1,655.1 | -46.9 | -- | 3.6 | |
| 331.5 | 10,821.7 | 1,557.8 | 187.8 | 16.1 | 12.8 | 57.7 | 6.8 | |
| 1,525.4 | 15,454.4 | 1,820.1 | 290.3 | 22.9 | 18.1 | 54.2 | 9.1 | |
| 579.0 | 9,218.1 | 876.0 | 174.0 | 25.3 | 32.4 | 52.3 | 14.6 | |
| 608.9 | 2,717.6 | 418.8 | 79.7 | 23.6 | 18.5 | 34.1 | 5.8 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Global Health IPO: Information analysis
2 min read•By Udhayaprakash
About Global Health
Global Health Limited engages in the provision of healthcare services in India. The company primarily offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, musculoskeletal... disorders and orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, plastic, aesthetic and reconstructive surgery, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, ayurveda, and dietetics and nutrition. It also offers lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, blood bank and e-ICU services, and health plans, as well as operates pharmacies. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurugram, India. Read more
-
Incorporated
2004
-
Chairman
Naresh Trehan
-
Managing Director
Naresh Trehan
-
Headquarters
New Delhi, Delhi
-
Website
Looking for more details about Global Health Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsResult For The Quarter Ended June 30 2026
30-Jul-2026No News & Announcements are available.
FAQs for Global Health
What is the current share price of Global Health Ltd Today?
The share price of Global Health Ltd is ₹1,405.60 (NSE) and ₹1,408.40 (BSE) as of 31-Jul-2026 IST. Global Health Ltd has given a return of 25.93% in the last 3 years.
What is the current PB & PE ratio of Global Health Ltd?
The P/E ratio of Global Health Ltd is 68.09 times as on 31-Jul-2026, a 7 premium to its peers’ median range of 63.60 times.
The P/B ratio of Global Health Ltd is 9.17 times as on 31-Jul-2026, a 0 premium to its peers’ median range of 9.17 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
66.85
|
9.50
|
|
2024
|
74.33
|
12.25
|
|
2023
|
43.28
|
5.82
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Global Health Ltd?
The 52-week high and low of Global Health Ltd are Rs 1,456.50 and Rs 956.00 as of 01-Aug-2026.
What is the market cap of Global Health Ltd?
Global Health Ltd has a market capitalisation of ₹ 37,868 Cr as on 31-Jul-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Global Health Ltd?
Before investing in Global Health Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.